Market Overview and Growth Outlook

The Single-Use Systems Market was valued at US$6.0 billion in 2024 and is projected to reach US$15.8 billion by 2031.

The Single-Use Systems Market is expected to grow at a CAGR of 15.1% in the long run.

The Single-Use Systems Market share landscape is shaped by product portfolios, bioprocess technology expertise, service offerings, regional presence, manufacturing capacity, and relationships with biopharmaceutical companies.

Request a free sample report:
https://www.stratviewresearch.com/Request-Sample/single-use-systems-market

Market Segmentation Analysis

By Product Type, Media Bags and Containers remain dominant, while Bioreactors grow fastest.

By Method Type, Filtration remains dominant, while Purification grows fastest.

By Application Type, Monoclonal Antibody Production remains dominant, while Patient-Specific Cell Therapies grow fastest.

By End-User Type, Biopharmaceutical Manufacturers remain dominant, while Contract Research Organizations & Manufacturers grow fastest.

Regional Market Insights

North America is anticipated to remain the dominant region.

China is expected to emerge as the fastest-growing market.

The competitive landscape benefits suppliers with established positions across both mature biopharmaceutical markets and rapidly expanding Asian markets.

Emerging Trends Shaping the Single-Use Systems Market

Product development is focused on stronger, more reliable disposable components.

In April 2023, Merck KGaA launched its Ultimus single-use process container film, designed for high durability and leak resistance in bioprocessing liquid applications.

Manufacturing capacity is also expanding.

In March 2020, Thermo Fisher Scientific Inc. invested more than US$475 million to strengthen biologics development, manufacturing, and cell and gene therapy capabilities at its St. Louis site, where expansion doubled single-use production capacity.

Key Growth Drivers of the Market

• Product reliability: Durable films and components reduce risks during fluid handling.

• Manufacturing capacity: Expanded production supports rising biologics demand.

• Advanced therapies: Cell and gene therapy manufacturing increases requirements for flexible single-use systems.

• Portfolio breadth: Suppliers covering multiple bioprocess steps can support more complete workflows.

• Regional presence: Global manufacturing and service networks strengthen customer access.

Competitive Landscape

The market is described as very competitive and highly consolidated, with leading suppliers capturing a major portion of demand.

Top Companies in the Market

Sartorius AG
Danaher Corporation
Thermo Fisher Scientific Inc.
Merck KGaA

Conclusion and Strategic Outlook

The Single-Use Systems Market is projected to grow from US$6.0 billion in 2024 to US$15.8 billion by 2031, supported by a 15.1% long-term CAGR.

Future competitive positioning will increasingly depend on product reliability, integrated bioprocess portfolios, advanced-therapy exposure, manufacturing scale, digital capabilities, and global service coverage.

FAQs – Single-Use Systems Market

1. What are the current and forecast market values?

The market was valued at US$6.0 billion in 2024 and is projected to reach US$15.8 billion by 2031.

2. What CAGR is expected?

The market is expected to grow at 15.1% in the long run.

3. How competitive is the market?

The market is described as very competitive and highly consolidated.

4. What product did Merck KGaA launch in April 2023?

Merck KGaA launched its Ultimus single-use process container film.

5. Which companies are highlighted as key players?

The source identifies Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., and Merck KGaA as key players.